Major depressive disorder: A loss of circadian synchrony?

被引:37
|
作者
Edgar, Nicole
McClung, Colleen A. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA
关键词
circadian rhythms; depression; post-mortem; SEASONAL AFFECTIVE-DISORDER; MOOD DISORDERS; GENE-EXPRESSION; CLOCK GENE; REVEALS PERSISTENT; ALZHEIMERS-DISEASE; BODY-TEMPERATURE; RHYTHMS; BRAIN; MOUSE;
D O I
10.1002/bies.201300086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circadian rhythms in the sleep/wake cycle, along with a range of physiological measures, are severely disrupted in individuals with major depressive disorder (MDD). Moreover, several central circadian genes have been implicated as potential genetic factors underlying the illness through candidate gene studies and some genome wide association studies. However, investigations into the molecular underpinnings of circadian disturbances in the human brain have been quite challenging. In their recent publication, Li and colleagues have used a novel approach to determine the rhythmic patterns of circadian gene expression in several regions of the human brain, and how these patterns are disrupted in MDD. Their findings demonstrate that in healthy subjects, several brain regions outside the suprachiasmatic nucleus (the master clock) exhibit diurnal gene expression patterns that are disrupted in the brains of MDD subjects. These findings will provide the foundation for future studies of gene-specific drug targets, and biomarkers for the disease.
引用
收藏
页码:940 / 944
页数:5
相关论文
共 50 条
  • [41] Aripiprazole - In major depressive disorder
    Weber, Juliane
    Lyseng-Williamson, Katherine A.
    Scott, Lesley J.
    CNS DRUGS, 2008, 22 (10) : 807 - 813
  • [42] Hyperthermia for Major Depressive Disorder?
    Berk, Michael
    Tye, Susannah
    Walder, Ken
    McGee, Sean
    JAMA PSYCHIATRY, 2016, 73 (10) : 1095 - 1096
  • [43] SITUATIONAL MAJOR DEPRESSIVE DISORDER
    HIRSCHFELD, RMA
    KLERMAN, GL
    ANDREASEN, NC
    CLAYTON, PJ
    KELLER, MB
    ARCHIVES OF GENERAL PSYCHIATRY, 1985, 42 (11) : 1109 - 1114
  • [44] MANAGING MAJOR DEPRESSIVE DISORDER
    COHEN, LJ
    FORMULARY, 1995, 30 : S2 - S2
  • [45] MicroRNAs in Major Depressive Disorder
    Fries, Gabriel R.
    Zhang, Wei
    Benevenuto, Deborah
    Quevedo, Joao
    REVIEWS ON BIOMARKER STUDIES IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, 2019, 1118 : 175 - 190
  • [46] The Mistreatment of Major Depressive Disorder
    Paris, Joel
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (03): : 148 - 151
  • [47] Temperament and major depressive disorder
    Elie G Karam
    Mariana M Salamoun
    Joumana S Yeretzian
    Zeina Mneimneh
    Aimee N Karam
    John Fayyad
    Annals of General Psychiatry, 9 (Suppl 1)
  • [48] Impairment in Major Depressive Disorder
    Pitchot, W
    Demyttenaere, K
    Albert, A
    Zhang, L
    De Cock, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S247 - S247
  • [49] Polypharmacy in major depressive disorder
    Touloumis, C.
    Ntounas, P.
    Tsopelos, C.
    Pappas, D.
    Mokas, C.
    Vasiliou, A.
    Chronopoulou, M.
    Dimitraka, M.
    Gogolakis, I.
    Marmarinou, C.
    Douzenis, A.
    Paraskevopoulou, A.
    Chatzimanolis, P.
    Stamou, S.
    Dimaki, S.
    Dimitriadis, D.
    Siouti, E.
    Konsta, A.
    Rizos, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 156 - 156
  • [50] AripiprazoleIn Major Depressive Disorder
    Juliane Weber
    Katherine A. Lyseng-Williamson
    Lesley J. Scott
    CNS Drugs, 2008, 22 : 807 - 813